Received Feb 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 1 | 091D21A | IM / LA |
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 2 | 017E21A | IM / LA |
Numerous immune system issues with recurrent illness including, rashes, chronic lymphadenopathy, neuropathic pain/tingling/burning sensations, dysautonomia, post-exertion malaise, persistent brain fog, frequent GI infections and respiratory infections. These symptoms started within 6 months after receiving COVID-19 vaccine.
Women's Multivitamin
Sulfa